These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Visual hallucinations in ophthalmological and neurological diseases]. Kerty E Tidsskr Nor Laegeforen; 1998 Dec; 118(30):4738-41. PubMed ID: 9914763 [TBL] [Abstract][Full Text] [Related]
3. Visual hallucinations and the Charles Bonnet syndrome. Ffytche DH Curr Psychiatry Rep; 2005 Jun; 7(3):168-79. PubMed ID: 15935130 [TBL] [Abstract][Full Text] [Related]
4. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. O'Brien J; Taylor JP; Ballard C; Barker RA; Bradley C; Burns A; Collerton D; Dave S; Dudley R; Francis P; Gibbons A; Harris K; Lawrence V; Leroi I; McKeith I; Michaelides M; Naik C; O'Callaghan C; Olsen K; Onofrj M; Pinto R; Russell G; Swann P; Thomas A; Urwyler P; Weil RS; Ffytche D J Neurol Neurosurg Psychiatry; 2020 May; 91(5):512-519. PubMed ID: 32213570 [TBL] [Abstract][Full Text] [Related]
5. Charles Bonnet syndrome. Sharma V Can J Psychiatry; 1991 May; 36(4):311-2. PubMed ID: 1868428 [No Abstract] [Full Text] [Related]
6. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Coletti Moja M; Milano E; Gasverde S; Gianelli M; Giordana MT Neurol Sci; 2005 Jul; 26(3):168-70. PubMed ID: 16086130 [TBL] [Abstract][Full Text] [Related]
7. The hodology of hallucinations. Ffytche DH Cortex; 2008 Sep; 44(8):1067-83. PubMed ID: 18586234 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease. Hanoglu L; Yildiz S; Cakir T; Hanoglu T; Yulug B Endocr Metab Immune Disord Drug Targets; 2019; 19(1):84-89. PubMed ID: 30160221 [TBL] [Abstract][Full Text] [Related]
9. Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease. Khan JC; Shahid H; Thurlby DA; Yates JR; Moore AT Ophthalmic Epidemiol; 2008; 15(3):202-8. PubMed ID: 18569816 [TBL] [Abstract][Full Text] [Related]
10. Acute Charles Bonnet Syndrome following Hughes procedure. Wilson ME; Pointdujour-Lim R; Lally S; Shields CL; Rabinowitz MP Orbit; 2016 Oct; 35(5):292-4. PubMed ID: 27467709 [TBL] [Abstract][Full Text] [Related]
11. Vision loss and hallucinations: perspectives from neurology and ophthalmology. Hamedani AG Curr Opin Neurol; 2021 Feb; 34(1):84-88. PubMed ID: 33230034 [TBL] [Abstract][Full Text] [Related]
12. Charles Bonnet syndrome (visual hallucinations) following enucleation. Tan CS; Sabel BA; Au Eong KG Eye (Lond); 2006 Dec; 20(12):1394-5; author reply 1395-6. PubMed ID: 16440017 [No Abstract] [Full Text] [Related]
13. Charles Bonnet syndrome. Ball C Br J Psychiatry; 1995 May; 166(5):677-8. PubMed ID: 7620757 [No Abstract] [Full Text] [Related]
14. Power spectral density and coherence analysis of eye disease with and without visual hallucination. Yildiz S; Yulug B; Kocabora MS; Hanoglu L Neurosci Lett; 2021 Jan; 740():135444. PubMed ID: 33127444 [TBL] [Abstract][Full Text] [Related]
15. [Complex visual hallucinations in a patient with bilateral visual impairment (Charles Bonnet syndrome)]. Asensio Sánchez VM; Merino Núñez F; Rivas Pastoriza A Arch Soc Esp Oftalmol; 2003 Jun; 78(6):327-9. PubMed ID: 12838466 [TBL] [Abstract][Full Text] [Related]
16. Perceived color of hallucinations in the Charles Bonnet Syndrome is related to residual color contrast sensitivity. Madill SA; Lascaratos G; Arden GB; ffytche DH J Neuroophthalmol; 2009 Sep; 29(3):192-6. PubMed ID: 19726940 [TBL] [Abstract][Full Text] [Related]
17. A comparison of visual hallucinations across disorders. Dudley R; Aynsworth C; Mosimann U; Taylor JP; Smailes D; Collerton D; McCarthy-Jones S; Urwyler P Psychiatry Res; 2019 Feb; 272():86-92. PubMed ID: 30579187 [TBL] [Abstract][Full Text] [Related]